Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging.
Akbari H, Kazerooni AF, Ware JB, Mamourian E, Anderson H, Guiry S, Sako C, Raymond C, Yao J, Brem S, O'Rourke DM, Desai AS, Bagley SJ, Ellingson BM, Davatzikos C, Nabavizadeh A. Akbari H, et al. Among authors: nabavizadeh a. Sci Rep. 2021 Jul 22;11(1):15011. doi: 10.1038/s41598-021-94560-3. Sci Rep. 2021. PMID: 34294864 Free PMC article.
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma.
Nazem A, Guiry SC, Pourfathi M, Ware JB, Anderson H, Iyer SK, Moon BF, Fan Y, Witschey WR, Rizi R, Bagley SJ, Desai A, O'Rourke DM, Brem S, Nasrallah M, Nabavizadeh A. Nazem A, et al. Among authors: nabavizadeh a. J Neurooncol. 2022 Feb;156(3):645-653. doi: 10.1007/s11060-022-03947-3. Epub 2022 Jan 19. J Neurooncol. 2022. PMID: 35043276
Distinguishing Progression from Pseudoprogression in Glioblastoma Using 18F-Fluciclovine PET.
Nabavizadeh A, Bagley SJ, Doot RK, Ware JB, Young AJ, Ghodasara S, Zhao C, Anderson H, Schubert E, Carpenter EL, Till J, Henderson F Jr, Pantel AR, Chen HI, Lee JYK, Amankulor NM, O'Rourke DM, Desai A, Nasrallah MP, Brem S. Nabavizadeh A, et al. J Nucl Med. 2023 Jun;64(6):852-858. doi: 10.2967/jnumed.122.264812. Epub 2022 Dec 22. J Nucl Med. 2023. PMID: 36549916 Free article.
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.
Bagley SJ, Logun M, Fraietta JA, Wang X, Desai AS, Bagley LJ, Nabavizadeh A, Jarocha D, Martins R, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz R, Jadlowsky JK, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen F, Sun Y, Gladney W, Barrett D, Nasrallah MP, Hwang WT, Ming GL, Song H, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke DM. Bagley SJ, et al. Among authors: nabavizadeh a. Nat Med. 2024 May;30(5):1320-1329. doi: 10.1038/s41591-024-02893-z. Epub 2024 Mar 13. Nat Med. 2024. PMID: 38480922 Clinical Trial.
Radio-pathomic approaches in pediatric neuro-oncology: Opportunities and challenges.
Familiar AM, Mahtabfar A, Fathi Kazerooni A, Kiani M, Vossough A, Viaene A, Storm PB, Resnick AC, Nabavizadeh A. Familiar AM, et al. Among authors: nabavizadeh a. Neurooncol Adv. 2023 Sep 13;5(1):vdad119. doi: 10.1093/noajnl/vdad119. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37841693 Free PMC article. Review.
Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation.
Familiar AM, Fathi Kazerooni A, Vossough A, Ware JB, Bagheri S, Khalili N, Anderson H, Haldar D, Storm PB, Resnick AC, Kann BH, Aboian M, Kline C, Weller M, Huang RY, Chang SM, Fangusaro JR, Hoffman LM, Mueller S, Prados M, Nabavizadeh A. Familiar AM, et al. Among authors: nabavizadeh a. Neuro Oncol. 2024 Sep 5;26(9):1557-1571. doi: 10.1093/neuonc/noae093. Neuro Oncol. 2024. PMID: 38769022 Review.
Radiomics and radiogenomics in pediatric neuro-oncology: A review.
Madhogarhia R, Haldar D, Bagheri S, Familiar A, Anderson H, Arif S, Vossough A, Storm P, Resnick A, Davatzikos C, Fathi Kazerooni A, Nabavizadeh A. Madhogarhia R, et al. Among authors: nabavizadeh a. Neurooncol Adv. 2022 May 27;4(1):vdac083. doi: 10.1093/noajnl/vdac083. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35795472 Free PMC article. Review.
Evolution and implementation of radiographic response criteria in neuro-oncology.
Ramakrishnan D, von Reppert M, Krycia M, Sala M, Mueller S, Aneja S, Nabavizadeh A, Galldiks N, Lohmann P, Raji C, Ikuta I, Memon F, Weinberg BD, Aboian MS. Ramakrishnan D, et al. Among authors: nabavizadeh a. Neurooncol Adv. 2023 Sep 13;5(1):vdad118. doi: 10.1093/noajnl/vdad118. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37860269 Free PMC article. Review.
63 results